Rectal bleeding after hypofractionated radiotherapy for prostate cancer: Correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding
- 1 November 2004
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 60 (4) , 1033-1039
- https://doi.org/10.1016/j.ijrobp.2004.07.695
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- How low is the α/β ratio for prostate cancer?International Journal of Radiation Oncology*Biology*Physics, 2003
- Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissueInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Is α/β for prostate tumors really low?International Journal of Radiation Oncology*Biology*Physics, 2001
- Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factorsRadiotherapy and Oncology, 2001
- Correlations between dose–surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose–responseInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406International Journal of Radiation Oncology*Biology*Physics, 2000
- Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation studyInternational Journal of Radiation Oncology*Biology*Physics, 1997